Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Br J Dermatol. 2018 Apr 2;178(5):1128–1134. doi: 10.1111/bjd.16350

Table 2.

Summary of assessments, their reliability and internal consistency

Instrument or subscore (reference range) Mean±SD Range Inter-observer reliability (ICC) Intra-observer or test-retest reliability (ICC) Cronbach’s alpha
iscorEB clinician (0–114) 11.3±10.9 0–47.1 0.96 0.89
 Skin (0–60) 4.1±5.4 0–26.1 0.88 0.91 0.85
 Mucosal (0–20) 3.2±2.0 0–8 0.82 0.70 0.88
 Internal organ (0–12) 1.6±1.7 0–7 0.97 0.88
 Laboratory abnormalities (0–11) 1.5±2.1 0–7 0.98 0.86
 Complications / procedures (0–11) 0.9±1.4 0–5 0.91 0.88
BEBS (0–100) 13.4±14.3 0–59 0.96 0.89
iscorEB patient
(0–120)
32.4±16.2 0–70 - 0.97 0.84
QOLEB (0–75), N=15 16.3±8.8 2–33 - 0.91
CDLQI (0–30), N=15 11.4±4.9 2–20 - 0.67

SD-standard deviation

BEBS- Epidermolysis Bullosa Severity score

QOLEB- Quality of Life Epidermolysis Bullosa

CDLQI- Childhood Dermatology Life Quality Index